Registre de correu electrònic: A Phase II Study of 2-Methoxyestradiol (2ME2) NanoCrystal(®) Dispersion (NCD) in Patients with Taxane-Refractory, Metastatic Castrate-Resistant Prostate Cancer (CRPC)